written on 07.09.2016

Hungary Pharma Report


This report offers companies, investors, policymakers, and stakeholders crucial insight into Hungary; a country with more than 100 years of history in pharmaceuticals and a leading regional role in the industry. Regulatory reform post-2008 has seen Hungary weather the storm of economic recession and re-establish itself as a hub for world-class R&D, with a concentration of pharma MNCs, a growing number of biotech SMEs, innovative research institutions, and a highly skilled and affordable workforce.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Hungarian healthcare and pharma sectors.

TAGS: Hungary,
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here